Trade Mark Journal No.2026/011 13 March 2026
UK00004347801 2 March 2026 (5)
ONKLARYV
International priority date claimed: 10 September 2025
(European Union Intellectual Property Office (EUIPO))
(019244756)
- Class 5
- Pharmaceutical preparations and substances.
AstraZeneca AB
Representative: Dennemeyer & Company Limited